Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
AstraZeneca
This is a First-time-in-human (FTiH) trial. Eligible participants will be randomized to receive AZD0292 or Placebo. Participants will receive pre-medication with an antihistamine prior to dosing with the study intervention. The study will comprise: 1. A Screening Period of maximum 28 days. 2. A Treatment Period 3. A Follow-up Period from Day 3 to Day 16 4. An extended Follow-up Period from Day 17 to Day 61 Participants will be involved in this study for a maximum duration of 13 weeks.
Age
18–60
Sex
ALL
Healthy volunteers
Accepted